Business Daily from THE HINDU group of publications
Thursday, Mar 15, 2007
ePaper
Business Daily from THE HINDU group of publications Thursday, Mar 15, 2007 ePaper |
|
|
|
|
|
|
|
Corporate
-
Alliances & Joint Ventures Marketing - Channels and Franchises Elder Pharma joins hands with Spanish co Our Bureau
Mumbai March 14 Elder Pharmaceuticals Ltd has entered into an alliance with Spain's Laboratorios Farmaceuticos Rovi SA to market advanced heparins or anti-thrombotics in India for treatment and prevention of diseases like deep vein thrombosis and pulmonary embolism. Heparins are used as anti-coagulants to prevent blood from clotting.
Joint Initiative
Laboratorios Farmaceuticos Rovi SA is a
The joint initiative between the two companies will see the introduction of Bemiparin in India — the patented, second-generation heparin used in the prevention and treatment of thrombo-embolic venous diseases — a note from the company said.
In India, Bemiparin is likely to be launched in a couple of months under the HIBOR brandname, and the price of the medicine would be firmed-up then, an industry representative familiar with the development said.
The total anti-thrombotic market in India is estimated to be about Rs 130 crore with products largely from multinational companies including Sanofi-Aventis and Novartis, the note added.
More Stories on :
Alliances & Joint Ventures |
Channels and Franchises |
Pharmaceuticals
Article
E-Mail
::
Comment
::
Syndication
::
Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2007, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|